Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
atezolizumab (Tecentriq) (1 trial)
chol-fus1 (1 trial)
diphenhydramine (benadryl) (1 trial)
docetaxel (taxotere) (1 trial)
erlotinib (tarceva) (1 trial)
osimertinib (tagrisso) (1 trial)
pembrolizumab (keytruda) (1 trial)
quaratusugene ozeplasmid (3 trials)
ramucirumab (cyramza) (1 trial)
urea (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Trials (4 total)
Trial APIs (10 total)